Guardant Faces $245 Million Patent Judgment A US federal court has ordered Guardant Health to pay more than $245.2 million in a patent dispute involving DNA sequencing technology. TwinStrand Biosciences and the University of Washington won the case. The US District Court for the District of Delaware entered its final judgment on August 21. The… Continue reading Guardant DNA Patent Dispute Ends With $245 Million Judgment
Guardant DNA Patent Dispute Ends With $245 Million Judgment